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When a new pathogen that causes a global epidemic in
humans, one key question is where it comes from. This
is especially important for a zoonotic infectious disease
that jumps from animals to humans. Knowing the ori-
gin of such a pathogen is critical to develop means to
block further transmission and to develop vaccines.
Discovery of the origin of a newly human pathogen
is a sophisticated process that requires extensive and
vigorous scientiﬁc validations and generally takes
many years, such as the cases for HIV-1 [1], SARS
[2] and MERS [3]. Unfortunately, before the natural
sources of new pathogens are clearly deﬁned, conspi-
racy theories that the new pathogens are man-made
often surface as the source. However, in all cases,
such theories have been debunked in history.
Infection from an emerging pathogenic coronavirus
was ﬁrst reported in December 2019 in China. It
has now aﬀected over 42,000 people and caused
over 1,000 deaths in 25 countries (https://2019ncov.
Chinacdc.Cn/2019-Ncov). The complete genome of
this new virus was quickly sequenced and made public
on January 12, only about 2 weeks after the disease
was ﬁrst observed [4]. It was named as 2019-nCoV
the following day by the World Health Organization
(WHO). Phylogenetic analysis shows that 2019-
nCoV is a new member of coronaviruses that infect
humans. It is genetically homogenous but distinct
from coronaviruses that cause SARS and MERS
[5,6]. However, it shares a high level of genetic simi-
larity (96.3%) with a bat coronavirus RaTG13 which
was obtained from bat in Yunnan in 2013, suggesting
that RaTG13-like viruses are most likely the reservoir,
but not the immediate sources of the current 2019-
nCoV viruses [7].
Lack of the deﬁnite origin of 2019-nCoV has led
to speculation that 2019-nCoV might be derived
from genetic manipulation or even for the purpose
of use as a bioweapon. This notion has been fully
debunked in the media. A recent informally pre-
sented report, however, showed that 2019-nCoV
had four insertions in the spike glycoprotein gene
that is critical for the virus to enter the target cells
when compared to other coronaviruses [8]. It was
claimed that these inserts were either identical or
similar to the motifs in the highly variable (V)
regions (V1, V4 and V5) in the envelope glyco-
protein or in the Gag protein of some unique HIV-
1 strains from three diﬀerent countries (Thailand,
Kenya and India). Together with the structure mod-
elling analysis, the authors speculated that these
motif insertions sharing similarity with HIV-1 pro-
teins could provide an enhanced aﬃnity towards
host cell receptors and increase the range of host
cells of 2019-nCoV. This study implies that 2019-
nCoV might be generated by gaining gene fragments
from the HIV-1 genome.
Current report conducted careful examination of
the sequences of 2019-nCoV, other CoV viruses and
HIV-1 as well as GenBank database. Our results
demonstrated no evidence that the sequences of these
four inserts are HIV-1 speciﬁc or the 2019-nCoV
viruses obtain these insertions from HIV-1. First, the
results of blast search of these motifs against GenBank
shows that the top 100 identical or highly homologous
hits are all from host genes of mammalian, insects, bac-
terial and others. There are only a few hits on corona-
viruses, but none of them are HIV-1 related. Blast
against viral sequence database also showed these
insertion sequences widely exist in all kinds of viruses
from bacteriophage, inﬂuenza, to giant eukaryotic
viruses (Table 1). More hits were found for corona-
viruses and a few also hit on HIV-1 sequences than
the search against the entire database (Table 1). How-
ever, while the 100%match between the insertion 1 and
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2 sequences and the HIV sequences were found in 19
entries, the matches between the insertion 3 and 4
sequences and HIV-1 sequences were rather poor
(from 42% to 88%). Moreover, the insertion 4 sequence
ambiguously hit multiple diﬀerent genes (gag, pol and
env) in the HIV-1 genome, suggesting that similarities
(as low as 42%) between them are too low to be reliable.
Search these four insertion sequences against HIV-1
Sequence Database (https://www.hiv.lanl.gov/
components/sequence/HIV/search/search.html)
yielded similar results. Sequences that completely
match the insertion 3 and 4 sequences were not
found in any HIV-1 sequences. This clearly shows
that these insertioin sequences are widely present in
living organisms including viruses, but not HIV-1
speciﬁc. All these regions in HIV-1 envelope glyco-
protein are highly variable with many large insertions
and deletions, indicating that they are not essential
for biological functions of HIV-1 envelope glyco-
protein. The detection of completely matched
sequences of 1 and 2 insertions in only a few HIV-1
strains demonstrated that four insertions are very
rare or not present among tens of thousands of natural
HIV-1 sequences. This also explains why four insertion
homolog sequences could only be independently found
in diﬀerent HIV-1 genomes [8]. Because of their poor
Table 1. Blast search results of four insertion sequences against sequence databases.
Database Gene source Insertion 1 TNGTKR Insertion 2 HKNNKS Insertion 3 RSYLTPGDSSSG Insertion 4 QTNSPRRA
Whole database CoV 2 (2) 0 3 (3) 2 (2)
HIV-1 0 0 0 0
Prokaryotic 27 (27) 3 (3) 74 (0) 66 (1)
Eukaryotic 71 (71) 97 (97) 23 (0) 32 (1)
Only viral database CoV 3 (3) 3 (3) 5 (3) 3 (2)
HIV-1 18 (18) 1 (1) 4 (0)* 6 (0)**
Other Eukaryotic viruses 49 (2) 66 (8) 69 (0) 62 (0)
Prokaryotic viruses 29 (13) 30 (1) 21 (0) 28 (0)
Unclassiﬁed virus 1 (1) 0 1 (0) 1 (0)
Top 100 hits are analyzed and the numbers of 100% matches are shown in parentheses. * Similarity at 67%; ** Random hits in Gag, Pro and Env sequences
with similarity between 42% and 88%.
Figure 1. Sequence and structure analysis of 2019-nCoV and bat coronaviruses. (A) Phylogenetic tree analysis of the spike gene
sequences. (B) Sequence alignment of suspected insertion sites between the 2019-nCoV and bat coronavirus sequences. The del-
etions in the alignment are shown as dashes. The numbers of insertions are indicated at the top of the alignment. (C) Structure
comparison of the four insertions in the CoV spike protein and HIV-1 gp120. 2019-nCoV structure was modelled using I-TASSER
server with default parameters. Only relevant domains with residues 1 to 708 (exclude residues from 305 to 603) were presented
as ribbon diagram. The four insertions were labelled and coloured in red, blue, green and magenta, respectively. HIV-1 gp120 struc-
ture (PDB 1GC1) is presented as ribbon diagram. V4, V5, V1/V2 and LE loops were labelled and coloured in red, blue, green, and
black, respectively.
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identities to and rareness in the HIV-1 sequences,
HIV-1 could not be the source for those insertion
sequences in the 2019-nCoV genome.
Second, these insertions are present not only in
2019-nCoV viruses but also in three betaCoV
sequences from bats: two (ZC45 and ZXC21) from
Zhejiang deposited in GenBank in 2018 and RaTG13
from Yunnan obtained in 2013 [8]. The RaTG13 is
much more similar to 2019-nCoV than both ZC45
and ZXC21 (Figure 1A). The similarity of the spike
protein between RaTG13 and 2019-nCoV is 97.7%.
In the RaTG13 genome, two inserts are identical
(HKNNKS and RSYLTPGDSSSG) to those in 2019-
nCoV, one has one T→ I substitution (TNGIKR),
and the fourth one misses the C-terminal 4 amino
acids (QTNS----) (Figure 1B). ZC45 and ZXC21 are
more divergent from 2019-nCoV than RaTG13, but
both also contain similar insertions at three insertion
sites, except insertion 4 (Figure 1B). Furthermore,
many other CoV viruses have similar insertions but
with diﬀerent sequences at the insertion 1 position.
These results clearly show that three out of four of
these inserts naturally exist in three bat CoV viruses
before 2019-nCoV was identiﬁed. This undoubtedly
refutes the possibility that 2019-nCoV is generated
through obtaining gene fragments from the HIV-1
genome. Instead, it is much more likely that 2019-
nCoV originated from RaTG13-like CoV viruses.
Third, insertions 1 and 2 in 2019-nCoV have 6-AA
motifs identical to those in V4 and V5 of certain HIV-1
gp120 isolates, which are structurally close to each
other but separated by a LE loop (Figure 1C) [9]. How-
ever, insertion 3 located between insertions 1 and 2 in
2019-nCoV has sequences similar (with deletions) to
those in the V1 region of HIV-1 gp120. V1 is far
away from V4 and V5 on the opposite side of gp120,
which should not interact with V4/V5 in gp120 (Figure
1C) but is now inserted between V4 and V5 in the
modelled the 2019-nCoV spike protein structure [10].
Insertion 4 was found in Gag protein of HIV-1 that
is not associated with viral entry. This insertion is
located too far to be considered to form the same struc-
tural unit with the other three insertions in the 2019-
nCoV spike protein (Figure 1C). We do not see any
selection beneﬁt or rationale for 2019-nCoV to obtain
and mix structurally unrelated parts of HIV-1 to gener-
ate a unique structure for its enhanced receptor bind-
ing as indicated by the authors [8].
How the three bat CoV viruses obtain those inserts
remains unknown. For any virus to obtain additional
insert sequences from other organisms, it requires
that it has direct interactions with other organisms,
most likely through homologous or non-homologous
recombination [11]. For bat CoV viruses to gain the
gene fragments from HIV-1, it will require both viruses
to co-infect the same cells. Because the host cells for bat
CoV viruses and HIV-1 are diﬀerent, the chance for
both to exchange genetic materials is negligible. On
the contrary, these motifs are widely present in various
mammalian cells and so it will be more likely for bat
CoV viruses to gain those motifs from the genomes of
their infected cells if recombination indeed occurs. How-
ever, extensive studies of more CoV viruses in wild and
domestic animals are warranted to address this question.
Identiﬁcation of the origins of these inserted
sequences in three bat CoV viruses and the new epi-
demic 2019-nCoV strain will be important for us to
understand how CoV viruses jump from animals to
humans and adapt in the latter. Current data showed
that RaTG13 is most closely related to 2019-nCoV
[7]. However, the genetic diﬀerence between them is
too high for RaTG13 to serve as the immediate ances-
tor of 2019-nCoV. Other viruses that are more closely
related to 2019-nCoV in intermediate animals like civet
for SARS and camel for MERS [3,12] are remained to
be identiﬁed. More studies are necessary to identify
the real source of 2019-nCoV. This may take a long
time to identify the origin of 2019-nCoV by screening
a large number of wild and domestic animals. In any
case, reducing or eliminating direct contacts with
wild animals will be critical to control the new epi-
demic infection diseases in the future.
The advances in bioinformatics analysis tools are
widely used to easily and rapidly analyse newly obtained
sequences. However, great care is required for compre-
hensive and thorough analysis to fully understand the
real biological implications of the new genomic infor-
mation. Biased, partial and incorrect analysis can
dangerously lead to conclusions that fuel conspiracies
and harm the process of true scientiﬁc discoveries and
the eﬀort to control the damage to public health.
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